Among the GLP-1 medications included in this study, the authors found semaglutide showed a stronger association with reduced AFib risk than liraglutide, dulaglutide and tirzepatide.
Research published in the New England Journal of Medicine demonstrates that semaglutide achieves remarkable weight reduction: participants lost an average of 14.9% of their body weight at 68 weeks with half achieving at least 15% weight loss and nearly one third losing 20% or more
Metabolic dysfunction-associated steatohepatitis investigations (e.g, ESSENCE, SURVODUTIDE in MASH, and Tirzepatide in MASH), 5
10 : 1123 Sunderland T, Molchan SE, Zubenko GS
Well tolerated by most highly allergic individuals, this product contains no corn, soy, yeast, milk or egg products, added sugars, salt, preservatives or tablet binders and coatings
It is a water-soluble, short-chain molecule similar to an amino acid